The Global Influenza Vaccines Market is estimated to be valued at USD 8.91 billion in 2025 and is projected to reach USD 14.59 billion by 2032, growing at a CAGR of 7.3%. Market growth is driven by rapid innovation in vaccine technologies, increasing government immunization programs, and rising awareness about the importance of annual influenza vaccination to reduce the disease burden....